Primary Record
199327-61-2
- In stock
- 9,284 g
- Purity
- 99.4 %
- CAS
- 199327-61-2
Compound Identifiers & Properties
- CAS
- 199327-61-2
- PubChem CID
- 135399673
- SMILES
- COC1=C(C=C2C(=C1)N=CNC2=O)OCCCN3CCOCC3
- Canonical SMILES
- COc1cc2nc[nH]c(=O)c2cc1OCCCN1CCOCC1
Names & Synonyms
- 199327-61-2
- Gefitinib Impurity 5
- Morfon
- 7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one
- 7-methoxy-6-(3-morpholinopropoxy)quinazolin-4(3H)-one
- Gefitinib Impurity 12
- Gefitinib Impurity C
- Gefitinib Impurity 3
- Gefitinib EP Impurity A
- intermediate of gefitinib
- MFCD12760130
- RefChem:546718
- R9YH59H93M
- WFUBWLXSYCFZEH-UHFFFAOYSA-N
- C16H21N3O4
- UNII-R9YH59H93M
- SCHEMBL829762
- SCHEMBL25281864
- SCHEMBL28431957
- SCHEMBL29478512
- SCHEMBL29478513
- CTK0H3924
- DTXSID90439401
- BCP26350
- KS-00000I4Z
- Gefitinib related compound A [USP]
- ANW-23857
- ZINC22062324
- 7-Methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one
- AKOS015917892
- AKOS025401601
- ACN-028885
- DS-1851
- FD16024
- RL02495
- 5alpha-Androstan-17beta-ol-3,7-dione
- CID10403660
- EC 429-400-7
- AC-22622
- AJ-80907
- AK-47996
- AN-30109
- SC-72020
- SY039369
- 7-Methoxy-6-(3-morpholinopropoxy)quinazolin-4(1h)-one
- 4(3H)-Quinazolinone, 7-methoxy-6-[3-(4-morpholinyl)propoxy]-
- AB0000528
- DB-066001
- HY-133779
- ST2406577
- 4CH-017695
- 7-methoxy-6-(3-morpholin-4-ylpropoxy)-1H-quinazolin-4-one
- AM20090617
- CS-0131955
- FT-0660445
- NS00077739
- X2633
- 7-Methoxy-6-[3-(4-morpholinyl)propoxy]-4(3H)-quinazolinone
- J1.646.599B
- 7-Methoxy-6-(3-morpholinopropoxy)-quinazolin-4(3H)-one
- A18404
- S-0018
- 327M612
- 4(1H)-Quinazolinone, 7-methoxy-6-[3-(4-morpholinyl)propoxy]-
- 7-methoxy-6-(3-morpholinopropoxy)-1H-quinazolin-4-one
- 7-Methoxy-6-(3-morpholinopropoxy)-3,4-dihydroquinazolin-4-one
- 7-Methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4(3H)-one
- F793847
- I14-8804
- 7-Methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazol
- 6-(3-Morpholinopropoxy)-7-methoxyquinazoline-4(3H)-one
- 7-Methoxy-6-(3-morpholinopropoxy)-4(3H)-quinazolinone
- 7-Methoxy-6-(3-morpholinopropoxy)quinazoline-4(3H)-one
- 7-Methoxy-6-(3-morpholinopropyloxy)quinazoline-4(3H)-one
- 7-methoxy-6-[3-(morpholin-4-yl)propoxy]-3,4-dihydroquinazolin-4-one
- 199327-61-2(N-2)
- 4(3H)-Quinazolinone,7-methoxy-6-[3-(4-morpholinyl)propoxy]-
- 7-Methoxy-6-(3-(4-morpholinyl)propoxy)-4(3H)-quinazolinone
- 7-methoxy-6-(3-morpholin-4-ylpropoxy)-3H-quinazolin-4-one
- 7-methoxy-6-(3-morpholinopropoxy)-3,4-dihydroquinazolin4-one
- 7-Methoxy-6-[3-(4-morpholinyl)propoxy]-4(1H)-quinazolinone
- 7-Methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4(1H)-one
- 7-methoxy-6-[3-(morpholin-4-yl)propoxy]-1,4-dihydroquinazolin-4-one
- 7-METHOXY-6-[3-(MORPHOLIN-4-YL)PROPOXY]-3H-QUINAZOLIN-4-ONE
- 4(3H)-Quinazolinone, 7-methoxy-6-[3-(4-morpholinyl)propoxy]-; 4(1H)-Quinazolinone, 7-methoxy-6-[3-(4-morpholinyl)propoxy]- (9CI); 7-Methoxy-6-[3-(4-morpholinyl)propoxy]-4(3H)-quinazolinone; 7-Methoxy-6-(3-(morpholin-4-yl)propoxy)-3H-quinazolin-4-one; 7-Methoxy-6-(3-morpholinopropoxy)-3,4-dihydroquinazolin-4-one; 7-Methoxy-6-[3-(4-morpholinyl)propoxy]quinazolin-4(3H)-one; Gefitinib Imp. A (EP); Gefitinib Impurity A
- 429-400-7
- 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;[containing < 0.5 % formamide (EC No 200-842-0)]7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing >= 0.5 % formamide (EC No 200-842-0)]